Vidiia Partners with Synnovis and the University of Surrey on Groundbreaking Aspergillus Detection Project 

This pioneering project brings together cutting-edge technology, clinical insight and academic rigour to address the urgent need for faster, decentralised and reliable detection of Aspergillus infections, particularly in immunocompromised patients. The collaboration aims to evaluate and accelerate the development of Vidiia’s AI-powered VH Platform and Rapid Extraction technologies, optimised for use in both clinical and research settings. 

Aspergillosis is an infection caused by a type of mould (fungus). The illnesses resulting from aspergillus infection usually affect the respiratory system, but their signs and severity vary greatly. The mould that triggers the illnesses, aspergillus, is everywhere – indoors and outdoors. Most strains of this mould are harmless, but a few can cause serious illnesses when people with weakened immune systems, underlying lung disease or asthma inhale their fungal spores. In some people, the spores trigger an allergic reaction. Other people develop mild to serious lung infections. The most serious form of aspergillosis – invasive aspergillosis – occurs when the infection spreads to blood vessels and beyond. Depending on the type of aspergillosis, treatment may involve observation, antifungal medications or, in rare cases, surgery.

The Aspergillus project is the latest in a series of targeted collaborations for Vidiia, whose mission is to democratise advanced molecular diagnostics through scalable hardware, robust reagents, and intelligent software tools. The outcomes of this project will inform future clinical deployment and validation studies across the UK and beyond. 

About Vidiia 

Vidiia is a UK-based molecular technology company revolutionising rapid and decentralised testing through AI-enabled platforms, rapid nucleic acid extraction, and user-friendly diagnostic workflows. Its flagship VH Platform is used in clinical, agricultural, and environmental testing across a growing number of applications. 

About Synnovis 

Synnovis is a partnership between Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust, and SYNLAB UK & Ireland. It provides integrated pathology services that support both clinical excellence and innovation across the NHS and beyond.